Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Michael Lucci

Physician Assistant, Medical Monroeville, PA Physician Assistant

NPI 1598731622 CMS profile 10775603

2566 Haymaker Rd Ste 203, Monroeville, PA 15146

Open in the dashboard

General payments

$6,381

91 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Michael Lucci of Monroeville, PA is reported in the CMS Open Payments database as having received $6,381 across 91 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 91st percentile of Physician Assistant, Medical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,531 18
2024 General $1,634 26
2023 General $1,431 23
2022 General $1,207 16
2021 General $577 8

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Michael Lucci
  • Physician Assistant, Medical median
  • Middle half of Physician Assistant, Medical
  • National median

In program year 2025, general payments to Michael Lucci were reported at $1,531. Among 16,675 Physician Assistant, Medical profiles paid that year, the median was $214 and the middle half received between $62 and $755.

Show as a table
Year Michael Lucci Physician Assistant, Medical median Middle half National median
2019 $0 $61 $19–$193 $163
2020 $0 $20 $14–$64 $114
2021 $577 $156 $41–$563 $132
2022 $1,207 $185 $55–$649 $149
2023 $1,431 $199 $58–$717 $160
2024 $1,634 $206 $62–$740 $164
2025 $1,531 $214 $62–$755 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Silk Road Medical, Inc. $2,043 20 payments
  2. Endologix, Inc. $1,762 25 payments
  3. Medtronic, Inc. $1,362 26 payments
  4. Boston Scientific Corporation $626 6 payments
  5. Veryan Medical Incorporated $189 2 payments
  6. Abiomed $107 2 payments
  7. W. L. Gore & Associates, Inc. $105 1 payment
  8. Smith+Nephew, Inc. $98 4 payments
  9. LeMaitre Vascular, Inc. $37 2 payments
  10. Atricure, Inc. $24 1 payment
  11. Other $29 2 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $6,381 91 payments
Products named General payments · program years 2021–2025
  1. ENROUTE Transcarotid Neuroprotection System Cardiology/Vascular Diseases $2,043 20 payments
  2. ENROUTE Transcarotid Stent $2,043 20 payments
  3. ENDURANT IIS $1,226 15 payments
  4. Alto Abdominal Stent Graft System $881 16 payments
  5. ENROUTE Transcarotid Neuroprotection System Cardiology/Vascular Diseases $752 6 payments
  6. ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter $752 6 payments
  7. ENHANCE Transcarotid Peripheral Access Kit Cardiology/Vascular Diseases $385 5 payments
  8. ENROUTE .014 Guidewire $385 5 payments
  9. AFX2 Bifurcated Endograft System $339 3 payments
  10. ENHANCE Transcarotid Peripheral Access Kit ENHANCE Transcarotid Peripheral Access Kit - PI $191 2 payments
  11. Other $1,518 32 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

214

Median for Physician Assistant: 241

Drug cost

$10,111

Median for Physician Assistant: $4,110

Branded share of claims

72%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 15 $8,614
Clopidogrel Clopidogrel Bisulfate Brand 139 $973
Atorvastatin Calcium Generic 38 $475
Oxycodone Hcl Generic 11 $37
Prednisone Generic 11 $12

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 4 billing codes

Paid by Medicare

$10,198

Medicare's payments for the services billed

Medicare patients

130

Average age 74

Services billed

135

47 women, 83 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 50%
Arthritis 50%
Diabetes 42%
Heart failure 32%
Chronic kidney disease 32%
COPD 28%
Atrial fibrillation 25%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

91 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant, Medical in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record